Cedars-Sinai Medical Center Neuromuscular Medicine (Neurology)

Topics

• Peripheral Neuropathies and Disorders 57
• Hereditary Neurological Disorders 39
• Amyotrophic Lateral Sclerosis Research 17
• Myasthenia Gravis and Thymoma 9
• Peripheral Nerve Disorders 5
• Autoimmune Neurological Disorders and Treatments 4
• Botulinum Toxin and Related Neurological Disorders 4
• Spinal Cord Injury Research 4
• Axon Guidance and Neuronal Signaling 3
• Genetic and Kidney Cyst Diseases 3
• Genetic Neurodegenerative Diseases 3
• Inflammatory Myopathies and Dermatomyositis 3

Most cited

1. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.

   European journal of neurology · 2021 · 436 citations · Richard Lewis

2. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.

   Journal of the peripheral nervous system : JPNS · 2021 · 372 citations · Richard Lewis

3. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.

   European journal of neurology · 2023 · 181 citations · Richard Lewis

4. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.

   The Lancet. Neurology · 2024 · 95 citations · Richard Lewis

5. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.

   Journal of the peripheral nervous system : JPNS · 2023 · 74 citations · Richard Lewis

6. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial.